You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.


The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
 
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

Hopes raised for OTC naloxone

By Dermot - 07th Oct 2015 | 6 views

Naloxone is an antidote used to reverse the effects of opioid drugs like heroin, morphine and methadone, if someone overdoses.

The project, launched in late May, involves 600 opiate users receiving take-home naloxone on prescription. The project is currently being evaluated, with a final report expected by the end of the year.

In an interview with the Medical Independent (MI) Dr Denis O’Driscoll, Chief Pharmacist, HSE Addiction Services, said after some initial problems, the project is working more smoothly now.

Dr O’Driscoll told MI that he is hoping that the evaluation will look at the current restrictions around the availability of naloxone.

“If you look across Europe, it is much more widely available than here. Best practice would be to make it more widely available,” he maintained.

“The fact that it is a prescription-only product makes it very difficult at the moment. I am hoping the evaluation will pick up on that. We need to then look to get that changed within the legislation.”

According to the latest figures available, a total of 350 people died in 2012 as a result of the toxic effects of one or more drugs.

<div> <p class=”continuedonfromMIstyles”>See feature ‘<a href=”../72783/a_shot_in_the_arm_to_tackle_overdose_deaths”>A shot in the arm to tackle overdose deaths</a>’

</div>

Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]